DETAILS, FICTION AND CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY

In Phase A, members will obtain various doses and schedules of oral ABBV-744 tablet to identify safe dosing program. Added individuals will likely be enrolled in the discovered monotherapy dosign routine. In Segment B, participants will acquire oral ruxolitinib and ABBV-744 might be presented as "include-on" therapy. In Phase C, members will receiv